SLC1A3 and amyotrophic lateral sclerosis: By modifying a commercially available kit’s method (Cappellano et al., 2021; Marchisio et al., 2020; Raineri et al., 2022), we were able to identify GLAST+ EVs in plasma specimens of ALS patients and HC by flow cytometry.